This report contains market size and forecasts of Pharma ADMET Testing in Global, including the following market information:
Global Pharma ADMET Testing Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Pharma ADMET Testing market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
In Vivo ADMET Testing Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pharma ADMET Testing include CMIC Holdings, Charles River Laboratories, WuXi AppTec, Promega Corporation, Merck KGaA, Agilient Technologies, Biovia (Dassault Systemes), Cyprotex Limited and Bio-Rad Laboratories and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharma ADMET Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma ADMET Testing Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Pharma ADMET Testing Market Segment Percentages, by Type, 2022 (%)
In Vivo ADMET Testing
In Vitro ADMET Testing
Global Pharma ADMET Testing Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Pharma ADMET Testing Market Segment Percentages, by Application, 2022 (%)
Systemic Toxicity Testing
Hepatotoxicity Testing
Renal Toxicity Testing
Neurotoxicity Testing
Others
Global Pharma ADMET Testing Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Pharma ADMET Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma ADMET Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharma ADMET Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CMIC Holdings
Charles River Laboratories
WuXi AppTec
Promega Corporation
Merck KGaA
Agilient Technologies
Biovia (Dassault Systemes)
Cyprotex Limited
Bio-Rad Laboratories
IQVIA
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pharma ADMET Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharma ADMET Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharma ADMET Testing Overall Market Size
2.1 Global Pharma ADMET Testing Market Size: 2022 VS 2030
2.2 Global Pharma ADMET Testing Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharma ADMET Testing Players in Global Market
3.2 Top Global Pharma ADMET Testing Companies Ranked by Revenue
3.3 Global Pharma ADMET Testing Revenue by Companies
3.4 Top 3 and Top 5 Pharma ADMET Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharma ADMET Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharma ADMET Testing Players in Global Market
3.6.1 List of Global Tier 1 Pharma ADMET Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharma ADMET Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pharma ADMET Testing Market Size Markets, 2022 & 2030
4.1.2 In Vivo ADMET Testing
4.1.3 In Vitro ADMET Testing
4.2 By Type - Global Pharma ADMET Testing Revenue & Forecasts
4.2.1 By Type - Global Pharma ADMET Testing Revenue, 2018-2023
4.2.2 By Type - Global Pharma ADMET Testing Revenue, 2023-2030
4.2.3 By Type - Global Pharma ADMET Testing Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharma ADMET Testing Market Size, 2022 & 2030
5.1.2 Systemic Toxicity Testing
5.1.3 Hepatotoxicity Testing
5.1.4 Renal Toxicity Testing
5.1.5 Neurotoxicity Testing
5.1.6 Others
5.2 By Application - Global Pharma ADMET Testing Revenue & Forecasts
5.2.1 By Application - Global Pharma ADMET Testing Revenue, 2018-2023
5.2.2 By Application - Global Pharma ADMET Testing Revenue, 2023-2030
5.2.3 By Application - Global Pharma ADMET Testing Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Pharma ADMET Testing Market Size, 2022 & 2030
6.2 By Region - Global Pharma ADMET Testing Revenue & Forecasts
6.2.1 By Region - Global Pharma ADMET Testing Revenue, 2018-2023
6.2.2 By Region - Global Pharma ADMET Testing Revenue, 2023-2030
6.2.3 By Region - Global Pharma ADMET Testing Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Pharma ADMET Testing Revenue, 2018-2030
6.3.2 US Pharma ADMET Testing Market Size, 2018-2030
6.3.3 Canada Pharma ADMET Testing Market Size, 2018-2030
6.3.4 Mexico Pharma ADMET Testing Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Pharma ADMET Testing Revenue, 2018-2030
6.4.2 Germany Pharma ADMET Testing Market Size, 2018-2030
6.4.3 France Pharma ADMET Testing Market Size, 2018-2030
6.4.4 U.K. Pharma ADMET Testing Market Size, 2018-2030
6.4.5 Italy Pharma ADMET Testing Market Size, 2018-2030
6.4.6 Russia Pharma ADMET Testing Market Size, 2018-2030
6.4.7 Nordic Countries Pharma ADMET Testing Market Size, 2018-2030
6.4.8 Benelux Pharma ADMET Testing Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Pharma ADMET Testing Revenue, 2018-2030
6.5.2 China Pharma ADMET Testing Market Size, 2018-2030
6.5.3 Japan Pharma ADMET Testing Market Size, 2018-2030
6.5.4 South Korea Pharma ADMET Testing Market Size, 2018-2030
6.5.5 Southeast Asia Pharma ADMET Testing Market Size, 2018-2030
6.5.6 India Pharma ADMET Testing Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Pharma ADMET Testing Revenue, 2018-2030
6.6.2 Brazil Pharma ADMET Testing Market Size, 2018-2030
6.6.3 Argentina Pharma ADMET Testing Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharma ADMET Testing Revenue, 2018-2030
6.7.2 Turkey Pharma ADMET Testing Market Size, 2018-2030
6.7.3 Israel Pharma ADMET Testing Market Size, 2018-2030
6.7.4 Saudi Arabia Pharma ADMET Testing Market Size, 2018-2030
6.7.5 UAE Pharma ADMET Testing Market Size, 2018-2030
7 Players Profiles
7.1 CMIC Holdings
7.1.1 CMIC Holdings Corporate Summary
7.1.2 CMIC Holdings Business Overview
7.1.3 CMIC Holdings Pharma ADMET Testing Major Product Offerings
7.1.4 CMIC Holdings Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.1.5 CMIC Holdings Key News
7.2 Charles River Laboratories
7.2.1 Charles River Laboratories Corporate Summary
7.2.2 Charles River Laboratories Business Overview
7.2.3 Charles River Laboratories Pharma ADMET Testing Major Product Offerings
7.2.4 Charles River Laboratories Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.2.5 Charles River Laboratories Key News
7.3 WuXi AppTec
7.3.1 WuXi AppTec Corporate Summary
7.3.2 WuXi AppTec Business Overview
7.3.3 WuXi AppTec Pharma ADMET Testing Major Product Offerings
7.3.4 WuXi AppTec Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.3.5 WuXi AppTec Key News
7.4 Promega Corporation
7.4.1 Promega Corporation Corporate Summary
7.4.2 Promega Corporation Business Overview
7.4.3 Promega Corporation Pharma ADMET Testing Major Product Offerings
7.4.4 Promega Corporation Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.4.5 Promega Corporation Key News
7.5 Merck KGaA
7.5.1 Merck KGaA Corporate Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Pharma ADMET Testing Major Product Offerings
7.5.4 Merck KGaA Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.5.5 Merck KGaA Key News
7.6 Agilient Technologies
7.6.1 Agilient Technologies Corporate Summary
7.6.2 Agilient Technologies Business Overview
7.6.3 Agilient Technologies Pharma ADMET Testing Major Product Offerings
7.6.4 Agilient Technologies Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.6.5 Agilient Technologies Key News
7.7 Biovia (Dassault Systemes)
7.7.1 Biovia (Dassault Systemes) Corporate Summary
7.7.2 Biovia (Dassault Systemes) Business Overview
7.7.3 Biovia (Dassault Systemes) Pharma ADMET Testing Major Product Offerings
7.7.4 Biovia (Dassault Systemes) Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.7.5 Biovia (Dassault Systemes) Key News
7.8 Cyprotex Limited
7.8.1 Cyprotex Limited Corporate Summary
7.8.2 Cyprotex Limited Business Overview
7.8.3 Cyprotex Limited Pharma ADMET Testing Major Product Offerings
7.8.4 Cyprotex Limited Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.8.5 Cyprotex Limited Key News
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Corporate Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Pharma ADMET Testing Major Product Offerings
7.9.4 Bio-Rad Laboratories Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.9.5 Bio-Rad Laboratories Key News
7.10 IQVIA
7.10.1 IQVIA Corporate Summary
7.10.2 IQVIA Business Overview
7.10.3 IQVIA Pharma ADMET Testing Major Product Offerings
7.10.4 IQVIA Pharma ADMET Testing Revenue in Global Market (2018-2023)
7.10.5 IQVIA Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pharma ADMET Testing Market Opportunities & Trends in Global Market
Table 2. Pharma ADMET Testing Market Drivers in Global Market
Table 3. Pharma ADMET Testing Market Restraints in Global Market
Table 4. Key Players of Pharma ADMET Testing in Global Market
Table 5. Top Pharma ADMET Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pharma ADMET Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pharma ADMET Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pharma ADMET Testing Product Type
Table 9. List of Global Tier 1 Pharma ADMET Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharma ADMET Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pharma ADMET Testing Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Pharma ADMET Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pharma ADMET Testing Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Pharma ADMET Testing Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Pharma ADMET Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pharma ADMET Testing Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Pharma ADMET Testing Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Pharma ADMET Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pharma ADMET Testing Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Pharma ADMET Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pharma ADMET Testing Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Pharma ADMET Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pharma ADMET Testing Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Pharma ADMET Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pharma ADMET Testing Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Pharma ADMET Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pharma ADMET Testing Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Pharma ADMET Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pharma ADMET Testing Revenue, (US$, Mn), 2023-2030
Table 30. CMIC Holdings Corporate Summary
Table 31. CMIC Holdings Pharma ADMET Testing Product Offerings
Table 32. CMIC Holdings Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 33. Charles River Laboratories Corporate Summary
Table 34. Charles River Laboratories Pharma ADMET Testing Product Offerings
Table 35. Charles River Laboratories Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 36. WuXi AppTec Corporate Summary
Table 37. WuXi AppTec Pharma ADMET Testing Product Offerings
Table 38. WuXi AppTec Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 39. Promega Corporation Corporate Summary
Table 40. Promega Corporation Pharma ADMET Testing Product Offerings
Table 41. Promega Corporation Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 42. Merck KGaA Corporate Summary
Table 43. Merck KGaA Pharma ADMET Testing Product Offerings
Table 44. Merck KGaA Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 45. Agilient Technologies Corporate Summary
Table 46. Agilient Technologies Pharma ADMET Testing Product Offerings
Table 47. Agilient Technologies Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 48. Biovia (Dassault Systemes) Corporate Summary
Table 49. Biovia (Dassault Systemes) Pharma ADMET Testing Product Offerings
Table 50. Biovia (Dassault Systemes) Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 51. Cyprotex Limited Corporate Summary
Table 52. Cyprotex Limited Pharma ADMET Testing Product Offerings
Table 53. Cyprotex Limited Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 54. Bio-Rad Laboratories Corporate Summary
Table 55. Bio-Rad Laboratories Pharma ADMET Testing Product Offerings
Table 56. Bio-Rad Laboratories Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
Table 57. IQVIA Corporate Summary
Table 58. IQVIA Pharma ADMET Testing Product Offerings
Table 59. IQVIA Pharma ADMET Testing Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Pharma ADMET Testing Segment by Type in 2022
Figure 2. Pharma ADMET Testing Segment by Application in 2022
Figure 3. Global Pharma ADMET Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pharma ADMET Testing Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Pharma ADMET Testing Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharma ADMET Testing Revenue in 2022
Figure 8. By Type - Global Pharma ADMET Testing Revenue Market Share, 2018-2030
Figure 9. By Application - Global Pharma ADMET Testing Revenue Market Share, 2018-2030
Figure 10. By Region - Global Pharma ADMET Testing Revenue Market Share, 2018-2030
Figure 11. By Country - North America Pharma ADMET Testing Revenue Market Share, 2018-2030
Figure 12. US Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Pharma ADMET Testing Revenue Market Share, 2018-2030
Figure 16. Germany Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 17. France Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Pharma ADMET Testing Revenue Market Share, 2018-2030
Figure 24. China Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 28. India Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Pharma ADMET Testing Revenue Market Share, 2018-2030
Figure 30. Brazil Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Pharma ADMET Testing Revenue Market Share, 2018-2030
Figure 33. Turkey Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Pharma ADMET Testing Revenue, (US$, Mn), 2018-2030
Figure 37. CMIC Holdings Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Charles River Laboratories Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. WuXi AppTec Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Promega Corporation Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Merck KGaA Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Agilient Technologies Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biovia (Dassault Systemes) Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cyprotex Limited Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bio-Rad Laboratories Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. IQVIA Pharma ADMET Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
